BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217 AND Diagnosis
42 results:

  • 1. Atypical CML: diagnosis and treatment.
    Breccia M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
    Ramamoorthy S; Lebrecht D; Schanze D; Schanze I; Wieland I; Andrieux G; Metzger P; Hess M; Albert MH; Borkhardt A; Bresters D; Buechner J; Catala A; De Haas V; Dworzak M; Erlacher M; Hasle H; Jahnukainen K; Locatelli F; Masetti R; Stary J; Turkiewicz D; Vinci L; Wlodarski MW; Yoshimi A; Boerries M; Niemeyer CM; Zenker M; Flotho C
    Br J Haematol; 2024 Feb; 204(2):595-605. PubMed ID: 37945316
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.
    Bonnet S; Carillo S; Legrand B; Burroni B; Lavabre-Bertrand T; Requirand G; Robert N; Fornero L; Al Mansoori A; Moreaux J; Cartron G; Gabellier L; Herbaux C
    Eur J Haematol; 2024 Mar; 112(3):475-478. PubMed ID: 37918825
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
    [No Abstract]    [Full Text] [Related]  

  • 5. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
    Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H
    Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
    Yan X; Qin TJ; Li B; Qu SQ; Pan LJ; Li FH; Liu NN; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):276-283. PubMed ID: 37356995
    [No Abstract]    [Full Text] [Related]  

  • 7. Co-occurring mutations in ASXL1, SRSF2, and setbp1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
    Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
    Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of novel PIEZO1::CBFA2T3 and INO80C::setbp1 fusion genes in an acute myeloid leukemia patient by RNA-seq.
    Li Y; Liu Y; Gao X; Zhao W; Zhou F; Liu H; Wang W
    Mol Biol Rep; 2023 Feb; 50(2):1961-1966. PubMed ID: 36472727
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
    Martelli MP; Rossi R; Venanzi A; Meggendorfer M; Perriello VM; Martino G; Spinelli O; Ciurnelli R; Varasano E; Brunetti L; Ascani S; Quadalti C; Cardinali V; Mezzasoma F; Gionfriddo I; Milano F; Pacini R; Tabarrini A; Bigerna B; Albano F; Specchia G; Vetro C; Di Raimondo F; Annibali O; Avvisati G; Rambaldi A; Falzetti F; Tiacci E; Sportoletti P; Haferlach T; Haferlach C; Falini B
    Blood; 2021 Dec; 138(25):2696-2701. PubMed ID: 34343258
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
    Romzova M; Smitalova D; Hynst J; Tom N; Loja T; Herudkova Z; Jurcek T; Stejskal L; Zackova D; Mayer J; Racil Z; Culen M
    Br J Haematol; 2021 Aug; 194(3):604-612. PubMed ID: 34212373
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Karantanos T; Gondek LP; Varadhan R; Moliterno AR; DeZern AE; Jones RJ; Jain T
    Br J Haematol; 2021 Jun; 193(6):1142-1150. PubMed ID: 34028801
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CSF3R T618I, setbp1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Patnaik MM; Lasho TL
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):450-459. PubMed ID: 33275756
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Atypical Chronic Myeloid leukemia: Where Are We Now?
    Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Additional gene mutations may refine the 2017 European leukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
    Eisfeld AK; Kohlschmidt J; Mims A; Nicolet D; Walker CJ; Blachly JS; Carroll AJ; Papaioannou D; Kolitz JE; Powell BE; Stone RM; de la Chapelle A; Byrd JC; Mrózek K; Bloomfield CD
    Leukemia; 2020 Dec; 34(12):3215-3227. PubMed ID: 32461631
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Analysis of Clinical Features and Prognosis of Patients with Chronic Neutrophil leukemia].
    Guo YJ; Wang Y; Wang LH; Zuo YB; Niu ZY; Lin FR; Zhang JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):82-87. PubMed ID: 32027257
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
    Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
    J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
    Hwang SM; Kim SM; Nam Y; Kim J; Kim S; Ahn YO; Park Y; Yoon SS; Shin S; Kwon S; Lee DS
    Leuk Res; 2019 Sep; 84():106190. PubMed ID: 31377458
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
    An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3.